Pens for Diabetes

A German company has developed the world’s first blood glucose meter that can wirelessly transmit your blood glucose test results. The GlucoTel is the first meter to support Bluetooth wireless technology.

0 comments - Oct 1, 2006 - Not Yet Rated

Interview With William Marshall, president of BD Medical—Diabetes Care

Why are today’s insulin syringes and pen needles better than ever?

0 comments - Apr 1, 2006 - Not Yet Rated

Do Your Insulin-Using Patients Know About Insulin Pens?

If you are an endocrinologist or primary care physician who works with diabetics, you have undoubtedly heard of the insulin pen. You probably know of their popularity in Europe or have heard testimonials from pen users about their ease of use.

0 comments - Apr 1, 2006 -

The Case for Insulin and Insulin Pens

Several months ago, I met Sophia, a woman in her mid-40s who had been struggling to manage her type 2 diabetes for years. Her blood glucose levels were typically well above 300 mg/dl, and she had an equally high A1C of 12.5%. She made it clear that the last thing she wanted was insulin.

0 comments - Apr 1, 2006 - Not Yet Rated

More and More Diabetes Patients Getting Turned On to Insulin Pens

Although they are equally effective when it comes to delivering insulin, more insulin-using patients expressed a preference to continue using an insulin pen after trying one.

0 comments - Apr 1, 2006 - Not Yet Rated

Patients Prefer Pens With Auditory and Sensory Confirmation

Because people with diabetes sometimes suffer from visual impairment as well as reduced manual dexterity, Japanese researchers assessed the reliability of dose selection and setting of five insulin devices by patients using auditory and sensory confirmation.

0 comments - Apr 1, 2006 - Not Yet Rated

blog

Levemir, Apidra and Lantus—Oh My! How Do the New Insulin Analogues Affect the Care of Your Patients?

In 1998, Eli Lilly & Co.’s rapid-acting insulin analogue lispro (Humalog) appeared on the U.S. market, followed in 2000 by Novo Nordisk’s rapid-acting counterpart aspart (NovoLog). Joined now by sanofi-aventis’ glulisine (Apidra), these rapid-acting insulins offer both convenience and improved blood glucose control to your patients who require bolus insulin.

0 comments - Apr 1, 2006 -

Site Rotation Suggestions to Consider During Pregnancy

Are you an expectant mother with diabetes? If so, are you wondering about the disappearance of infusion sites as your baby grows and your abdomen expands? Do you anticipate that “pinching an inch” will become more of a challenge? Are you concerned about the angle and depth of insertion, and how often you should rotate insertion sites? Here are a few suggestions for you:

0 comments - Mar 1, 2006 - Not Yet Rated

New Recommendations for Safe Needle Disposal

It is estimated that that between eight and nine million people use syringes at home, generating two to three billion used needles each year in the United States. About two-thirds of the needle users are injecting for medicinal purposes like diabetes.

0 comments - Nov 1, 2005 - Not Yet Rated

Is an Insulin Pen Right for You?

I often wonder why insulin pens are so popular in Europe, yet usage in the United States continues to hover around 12 percent. I think the main reason is that many healthcare providers are not familiar with insulin pens or how to train people to use them, so they don’t recommend pens to their patients.

0 comments - Nov 1, 2005 -

Diabetes Health

Topics

Topics

Topics

Diabetes Health Medical Disclaimer